Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 20207235)

1.

What is the value for money of prenatal carrier screening for spinal muscular atrophy? Too soon to say.

Grosse SD.

Am J Obstet Gynecol. 2010 Mar;202(3):209-11. doi: 10.1016/j.ajog.2010.01.031. No abstract available.

PMID:
20207235
2.

The cost-effectiveness of prenatal screening for spinal muscular atrophy.

Little SE, Janakiraman V, Kaimal A, Musci T, Ecker J, Caughey AB.

Am J Obstet Gynecol. 2010 Mar;202(3):253.e1-7. doi: 10.1016/j.ajog.2010.01.032.

PMID:
20207244
3.

Prenatal diagnosis for risk of spinal muscular atrophy.

Cuscó I, Barceló MJ, Soler C, Parra J, Baiget M, Tizzano E.

BJOG. 2002 Nov;109(11):1244-9.

PMID:
12452462
4.

[The gene of spinal muscular atrophy localized. Possibilities for prenatal diagnosis].

Blennow ES, Bui TH, Söderhäll S, Anvret M, Nordenskjöld M.

Lakartidningen. 1993 Jan 27;90(4):269-75. Swedish. No abstract available.

PMID:
8433608
5.

Clinical and molecular diagnosis of spinal muscular atrophy.

Panigrahi I, Kesari A, Phadke SR, Mittal B.

Neurol India. 2002 Jun;50(2):117-22. Review.

6.

Preserved umbilical cord facilitates antenatal diagnosis of spinal muscular atrophy.

Kabra M, Arora S, Maria A, Aggarwal R.

Indian Pediatr. 2003 May;40(5):415-8.

7.

[Infantile spinal muscular atrophy. An unusual disease with various differential diagnoses].

Solders G.

Lakartidningen. 1993 Jan 27;90(4):268-9. Swedish. No abstract available.

PMID:
8433607
8.

Rapid diagnosis of infantile spinal muscular atrophy by direct amplification of amniocyte and CVS DNA.

MacKenzie A, Besner A, Roy N.

J Med Genet. 1993 Feb;30(2):162-3. No abstract available.

9.

Rapid prenatal diagnosis of spinal muscular atrophy by denaturing high-performance liquid chromatography system.

Shaw SW, Cheng PJ, Chang SD, Lin YT, Hung CC, Chen CP, Su YN.

Acta Obstet Gynecol Scand. 2008;87(9):960-8. doi: 10.1080/00016340802307779.

PMID:
18720039
10.

Prenatal diagnosis of Werdnig-Hoffmann disease in China.

Feng J, Toshiyuki Y.

Chin Med J (Engl). 2003 May;116(5):673-5.

PMID:
12875676
11.

[Gene diagnosis for spinal muscular atrophy and its application study].

Cao DH, Ren MH, Lin CK, Cui WT, Ma HW, Wu YY, Jin CL.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Jun;26(3):306-9. doi: 10.3760/cma.j.issn.1003-9406.2009.03.015. Chinese.

PMID:
19504445
12.

The cost-effectiveness of prenatal carrier screening for cystic fibrosis.

Lieu TA, Watson SE, Washington AE.

Obstet Gynecol. 1994 Dec;84(6):903-12.

PMID:
7970468
13.

Rapid genetic diagnosis and prenatal diagnosis of spinal muscular atrophy by denaturing high-performance liquid chromatography.

Zhu HY, Wu LQ, Pan Q, Tang BS, Liang DS, Long ZG, Dai HP, Xia K, Xia JH.

Chin Med J (Engl). 2006 Jul 20;119(14):1222-5. No abstract available.

PMID:
16863617
14.

[Indirect molecular-genetic family study and prenatal diagnosis of infantile spinal muscular atrophy].

Heber U, Müller CR.

Klin Padiatr. 1994 Jan-Feb;206(1):30-5. German.

PMID:
8152204
15.

Prenatal screening for cystic fibrosis carriers: an economic evaluation.

Rowley PT, Loader S, Kaplan RM.

Am J Hum Genet. 1998 Oct;63(4):1160-74.

16.

Permissibility of prenatal diagnosis and abortion for fetuses with severe genetic disorder: type 1 spinal muscular atrophy.

Sasongko TH, Salmi AR, Zilfalil BA, Albar MA, Mohd Hussin ZA.

Ann Saudi Med. 2010 Nov-Dec;30(6):427-31. doi: 10.4103/0256-4947.72259.

17.

Prenatal prediction of childhood-onset spinal muscular atrophy (SMA) in Turkish families.

Savas S, Eraslan S, Kantarci S, Karaman B, Acarsoz D, Tükel T, Cogulu O, Ozkinay F, Basaran S, Aydinli K, Yuksel-Apak M, Kirdar B.

Prenat Diagn. 2002 Aug;22(8):703-9.

PMID:
12210580
18.

Spinal muscular atrophy (SMA) after conception using gametes from anonymous donors: recommendations for the future.

Callum P, Urbina MT, Falk RE, Alvarez-Diaz JA, Benjamin I, Sims CA.

Fertil Steril. 2010 Feb;93(3):1006.e1-2. doi: 10.1016/j.fertnstert.2009.10.039. Epub 2009 Dec 3.

PMID:
19962137
19.

Evaluating the benefits of antenatal screening: an alternative approach.

Shackley P, Cairns J.

Health Policy. 1996 May;36(2):103-15.

PMID:
10158764
20.

Cost-effectiveness analysis of prenatal population-based fragile X carrier screening.

Musci TJ, Caughey AB.

Am J Obstet Gynecol. 2005 Jun;192(6):1905-12; discussion 1912-5.

PMID:
15970847
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk